Analysis: Positioning to Benefit within Euronet Worldwide, Innospec, Zosano Pharma, Ardelyx, Crown Castle International, and Aldeyra Therapeutics — Research Highlights Growth, Revenue, and Consolidated Results

Loading...
Loading...

NEW YORK, April 05, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Euronet Worldwide, Inc. EEFT, Innospec Inc. IOSP, Zosano Pharma Corporation ZSAN, Ardelyx, Inc. ARDX, Crown Castle International Corporation CCI, and Aldeyra Therapeutics, Inc. ALDX, including updated fundamental summaries, consolidated fiscal reporting, and fully-qualified certified analyst research.

Complimentary Access: Research Reports

Full copies of recently published reports are available to readers at the links below.

EEFT DOWNLOAD: http://Fundamental-Markets.com/register/?so=EEFT
IOSP DOWNLOAD: http://Fundamental-Markets.com/register/?so=IOSP
ZSAN DOWNLOAD: http://Fundamental-Markets.com/register/?so=ZSAN
ARDX DOWNLOAD: http://Fundamental-Markets.com/register/?so=ARDX
CCI DOWNLOAD: http://Fundamental-Markets.com/register/?so=CCI
ALDX DOWNLOAD: http://Fundamental-Markets.com/register/?so=ALDX

(You may have to copy and paste the link into your browser and hit the [ENTER] key)

The new research reports from Fundamental Markets, available for free download at the links above, examine Euronet Worldwide, Inc. EEFT, Innospec Inc. IOSP, Zosano Pharma Corporation ZSAN, Ardelyx, Inc. ARDX, Crown Castle International Corporation CCI, and Aldeyra Therapeutics, Inc. ALDX on a fundamental level and outlines the overall demand for their products and services in addition to an in-depth review of the business strategy, management discussion, and overall direction going forward. Several excerpts from the recently released reports are available to today's readers below.

-----------------------------------------

Loading...
Loading...

Important Notice: the following excerpts are not designed to be standalone summaries and as such, important information may be missing from these samples. Please download the entire research report, free of charge, to ensure you are reading all relevant material information. All information in this release was accessed April 3rd, 2018. Percentage calculations are performed after rounding. All amounts in millions (MM), except per share amounts.

-----------------------------------------

EURONET WORLDWIDE, INC. (EEFT) REPORT OVERVIEW

Euronet Worldwide's Recent Financial Performance

For the three months ended December 31st, 2017 vs December 31st, 2016, Euronet Worldwide reported revenue of $604.65MM vs $519.83MM (up 16.32%) and basic earnings per share -$0.44 vs $0.56. For the twelve months ended December 31st, 2017 vs December 31st, 2016, Euronet Worldwide reported revenue of $2,252.42MM vs $1,958.62MM (up 15.00%) and basic earnings per share $2.99 vs $3.34 (down 10.48%). Euronet Worldwide is expected to report earnings on April 24th, 2018. The report will be for the fiscal period ending March 31st, 2018. The reported EPS for the same quarter last year was $0.67. The estimated EPS forecast for the next fiscal year is $5.75 and is expected to report on February 5th, 2019.

To read the full Euronet Worldwide, Inc. (EEFT) report, download it here: http://Fundamental-Markets.com/register/?so=EEFT

-----------------------------------------

INNOSPEC INC. (IOSP) REPORT OVERVIEW

Innospec's Recent Financial Performance

For the three months ended December 31st, 2017 vs December 31st, 2016, Innospec reported revenue of $353.80MM vs $237.80MM (up 48.78%) and basic earnings per share -$0.20 vs $0.91. For the twelve months ended December 31st, 2017 vs December 31st, 2016, Innospec reported revenue of $1,306.80MM vs $883.40MM (up 47.93%) and basic earnings per share $2.56 vs $3.39 (down 24.48%). Innospec is expected to report earnings on May 8th, 2018. The report will be for the fiscal period ending March 31st, 2018. The reported EPS for the same quarter last year was $1.00. The estimated EPS forecast for the next fiscal year is $4.65 and is expected to report on February 12th, 2019.

To read the full Innospec Inc. (IOSP) report, download it here: http://Fundamental-Markets.com/register/?so=IOSP

-----------------------------------------

ZOSANO PHARMA CORPORATION (ZSAN) REPORT OVERVIEW

Zosano Pharma's Recent Financial Performance

Zosano Pharma is expected to report earnings on May 8th, 2018. The report will be for the fiscal period ending March 31st, 2018. The reported EPS for the same quarter last year was -$6.80.

To read the full Zosano Pharma Corporation (ZSAN) report, download it here: http://Fundamental-Markets.com/register/?so=ZSAN

-----------------------------------------

ARDELYX, INC. (ARDX) REPORT OVERVIEW

Ardelyx's Recent Financial Performance

For the twelve months ended December 31st, 2017 vs December 31st, 2016, Ardelyx reported revenue of $42.00MM vs $0.00MM and basic earnings per share -$1.36 vs -$2.80. Ardelyx is expected to report earnings on May 4th, 2018. The report will be for the fiscal period ending March 31st, 2018. The reported EPS for the same quarter last year was -$0.59. The estimated EPS forecast for the next fiscal year is -$1.74 and is expected to report on March 13th, 2019.

To read the full Ardelyx, Inc. (ARDX) report, download it here: http://Fundamental-Markets.com/register/?so=ARDX

-----------------------------------------

CROWN CASTLE INTERNATIONAL CORPORATION (CCI) REPORT OVERVIEW

Crown Castle International's Recent Financial Performance

For the three months ended December 31st, 2017 vs December 31st, 2016, Crown Castle International reported revenue of $1,238.09MM vs $1,032.42MM (up 19.92%) and basic earnings per share $0.15 vs $0.36 (down 58.33%). For the twelve months ended December 31st, 2017 vs December 31st, 2016, Crown Castle International reported revenue of $4,355.61MM vs $3,921.23MM (up 11.08%) and basic earnings per share $1.01 vs $0.95 (up 6.32%). Crown Castle International is expected to report earnings on April 23rd, 2018. The report will be for the fiscal period ending March 31st, 2018. The reported EPS for the same quarter last year was $1.24. The estimated EPS forecast for the next fiscal year is $5.71 and is expected to report on January 23rd, 2019.

To read the full Crown Castle International Corporation (CCI) report, download it here: http://Fundamental-Markets.com/register/?so=CCI

-----------------------------------------

ALDEYRA THERAPEUTICS, INC. (ALDX) REPORT OVERVIEW

Aldeyra Therapeutics' Recent Financial Performance

Aldeyra Therapeutics is expected to report earnings on May 21st, 2018. The report will be for the fiscal period ending March 31st, 2018. The reported EPS for the same quarter last year was -$0.37. The estimated EPS forecast for the next fiscal year is -$2.06 and is expected to report on April 4th, 2019.

To read the full Aldeyra Therapeutics, Inc. (ALDX) report, download it here: http://Fundamental-Markets.com/register/?so=ALDX

-----------------------------------------

ABOUT FUNDAMENTAL MARKETS

Fundamental Markets serves thousands of members and have provided research through some of the world's leading brokerages for over a decade–and continue to be one of the best information sources for investors and investment professionals worldwide. Fundamental Markets' roster boasts decades of financial experience and includes top financial writers, FINRA® BrokerCheck® certified professionals with current and valid CRD® number designations, as well as Chartered Financial Analyst® (CFA®) designation holders, to ensure up to date factual information for active readers on the topics they care about.

REGISTERED MEMBER STATUS

Fundamental Markets' oversight and audit staff are registered analysts, brokers, and/or financial advisers ("Registered Members") working within Equity Research, Media, and Compliance departments. Fundamental Markets' roster includes qualified CFA® charterholders, licensed securities attorneys, and registered FINRA® members holding duly issued CRD® numbers. Current licensed status of several Registered Members at Fundamental Markets have been independently verified by an outside audit firm, including policy and audit records duly executed by Registered Members. Complaints, concerns, questions, or inquiries regarding this release should be directed to Fundamental Markets' Compliance department by Phone, at +1 667-401-0010, or by E-mail at compliance@Fundamental-Markets.com.

LEGAL NOTICES

Information contained herein is not an offer or solicitation to buy, hold, or sell any security. Fundamental Markets, Fundamental Markets members, and/or Fundamental Markets affiliates are not responsible for any gains or losses that result from the opinions expressed. Fundamental Markets makes no representations as to the completeness, accuracy, or timeliness of the material provided and all materials are subject to change without notice. Fundamental Markets has not been compensated for the publication of this press release by any of the above mentioned companies. Fundamental Markets is not a financial advisory firm, investment adviser, or broker-dealer, and does not undertake any activities that would require such registration. For our full disclaimer, disclosure, and terms of service please visit our website.

Media Contact:
Andrew Duffie, Media Department
Office: +1 667-401-0010
E-mail: media@Fundamental-Markets.com

© 2018 Fundamental Markets. All Rights Reserved. For republishing permissions, please contact a partner network manager at partnership@Fundamental-Markets.com.

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

FINRA®, BrokerCheck®, and CRD® are registered trademarks owned by Financial Industry Regulatory Authority, Inc.


Loading...
Loading...
Posted In: Press Releases
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...